Article
Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
Neurology - 1 Feb 1998
Smith G E, Bohac D L, Waring S C, Kokmen E, Tangalos E G, Ivnik R J, Petersen R C
Abstract excerpt
We examined the association of apolipoprotein E (apo E) genotype with cognitive performance in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients and in normal subjects. One hundred fifty-seven AD patients, 35 MCI patients who developed AD during longitudinal follow-up, and 341 normal control subjects from the Mayo Clinic Alzheimer's Disease Patient Registry were studied. All participants were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.